No quarantine relief for Indians despite UK nod to Covishield as qualified vaccine

Published On 2021-09-23 08:30 GMT | Update On 2021-09-23 12:26 GMT

New Delhi: Indian travellers vaccinated with two doses of Covishield will still have to undergo 10 days of quarantine in the UK even as the vaccine has been approved under the revised British guidelines for travel, according to UK officials.

They said the main issue is vaccine certification and not the Covishield vaccine and that both India and the UK are holding talks to mutually resolve the matter.

Referring to the latest guidelines issued by the UK government that will come into effect on October 4, the officials said on Wednesday that London does not have any problem with the Covishield vaccine but there are certain issues related to vaccine certification in India. They said the UK is engaging with the government of India to explore how it could expand its recognition of vaccine certification to people vaccinated by a relevant public health body in India.

Quoting new guidelines, the officials said Indian travellers to the UK must follow the "non-vaccinated rules" set out by the authorities. India had on Tuesday warned of "reciprocal measures" if the UK does not address its concerns over the new travel rules relating to COVID-19 vaccine certification with Foreign Secretary Harsh Vardhan Shringla describing these norms as "discriminatory".

External Affairs Minister S Jaishankar also took up the issue of Covishield-vaccinated travellers being required to quarantine in the UK with newly-appointed British Foreign Secretary Elizabeth Truss at a meeting in New York on Tuesday.

On Wednesday, the UK government added Covishield, the Indian-manufactured Oxford/AstraZeneca COVID-19 vaccine, to an updated international travel advisory.

"The UK is committed to opening up international travel again as soon as is practicable and this announcement is a further step to enable people to travel more freely again, in a safe and sustainable way, while protecting public health," a spokesperson in the British High Commission said.

"We are engaging with the Government of India to explore how we could expand UK recognition of vaccine certification to people vaccinated by a relevant public health body in India," the official said.

Read also: Serum Institute CEO sets aside Rs 10 crore to support students travelling abroad

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

No quarantine relief for Indians despite UK nod to Covishield as qualified vaccine

Similar News

Granules India arm gets 1 USFDA observation for Hyderabad facility

CDSCO Panel Clears PURE & CURE's Sickle Cell Trial With Conditions On Sample Size, Sites

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France

Zydus Wellness sees exit of Head-R&D, Head-GDSO

Natco Pharma appoints TC Mallikarjun as Vice President - QC at Kothur Pharma Division

Veeda Clinical Research Gets Expert Committee Nod To Conduct BA/BE Study Of Ibrutinib For Export

Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside